Utah Medical Products, Inc.

UTMD Healthcare Medical Instruments & Supplies

Utah Medical Products, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, down 5.83% from fiscal 2024.

Revenue
−14.3%
EPS
−10.6%
Free cash flow
−55.7%

Quarter to June 2026, against a year earlier

70.54 0.50 −0.70%
Market cap
$202.4M
P/E
21.7×
Fwd P/E
28.7×
Dividend yield
1.74%
F-score
6/9
Altman Z
36.25
Beneish M
−2.68
Dividend safety
82/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
6 6 6 7 9 6 8 5 6 9
P/E ratio
16.08 15.56 18.27 21.68 24.69 28.77 27.39 16.78 34.63 22.24
P/S ratio
4.71 5.26 6.03 6.80 7.43 7.31 8.56 7.38 7.12 6.82
Altman Z-Score
36.25 28.36 28.77 25.99 28.83 23.54 30.64 20.37 15.40 26.77
Altman Z″-Score (non-manufacturers)
47.39 33.27 27.94 21.31 21.52 19.59 19.65 16.86 13.10 18.07
P/FCF ratio
12.66 14.73 14.00 17.49 0.00 0.00 0.00 17.92 19.27 23.86
Beneish M-Score
(2.68) (2.12) (3.06) (2.85) (2.59) (3.08) (2.23) (2.37) (3.00) (2.83)
P/Operating CF
52.15 73.32 56.82 62.60 73.13 53.37 71.17 69.13 64.30 79.12
P/B ratio
1.52 1.83 2.36 3.11 3.40 3.00 3.97 3.48 3.77 3.87
Dividend Safety Score
82 — — — — — — — — —
EV/Sales
2.51 3.26 4.20 5.38 6.21 6.11 7.67 6.18 6.18 6.17
EV/EBITDA
6.70 8.11 9.12 10.47 11.65 12.32 14.67 12.00 11.75 12.75
EV/FCF
6.74 9.12 9.75 13.85 (873.06) (149.60) (80.21) 15.02 16.72 21.60
Current Ratio
37.62 25.64 22.56 15.09 19.53 16.42 15.92 11.58 9.32 11.41
Net Debt/EBITDA
(5.95) (5.05) (4.01) (2.79) (2.33) (2.47) (1.75) (2.36) (1.83) (1.39)
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
9.54% 11.29% 13.72% 14.88% 14.09% 10.59% 15.50% 22.21% 11.54% 17.46%
ROA
9.21% 10.76% 12.83% 13.76% 13.01% 9.75% 14.06% 19.28% 10.07% 15.61%
ROIC
21.26% 24.66% 29.58% 31.55% 25.56% 16.72% 18.90% 30.85% 31.13% 23.59%
Return on Tangible Assets
10.74% 13.56% 14.84% 17.49% 18.48% 15.47% 23.69% 28.11% 15.32% 29.28%
Average Days of Receivables
33.37 36.53 24.64 38.66 38.19 35.52 36.90 34.38 31.93 29.82
Earnings Yield
6.22% 6.43% 5.47% 4.61% 4.05% 3.48% 3.65% 5.96% 2.89% 4.50%
Free Cash Flow Yield
7.90% 6.79% 7.14% 5.72% (0.10%) (0.56%) (1.12%) 5.58% 5.19% 4.19%
Free Cash Flow per Share
4.42 4.17 5.96 5.59 5.66 5.27 (1.21) 4.64 4.12 2.99
Book value per Share
36.81 33.52 35.36 31.41 29.38 28.11 27.17 23.86 21.01 18.46
Free Cash Flow
14.32 14.62 21.64 20.33 20.65 19.28 (4.48) 17.29 15.31 11.23
EV/EBIT
8.47 9.81 12.58 14.22 16.14 18.80 20.40 13.89 13.46 14.98
Other line items

Show all line items

Columns are period end dates